Loading...

Advicenne S.A.

ADVIC.PA•EURONEXT
Healthcare
Biotechnology
€6.50
€0.00(0.00%)

Advicenne S.A. (ADVIC.PA) Company Profile & Overview

Explore Advicenne S.A.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Advicenne S.A. (ADVIC.PA) Company Profile & Overview

Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy. The company also provides ADV6209, an oral liquid solution for children to reduce anxiety and to improve their immobility. Advicenne S.A. was founded in 2007 and is based in Paris, France.

SectorHealthcare
IndustryBiotechnology
CEOAndr Ulmann

Contact Information

https://www.advicenne.com
33466055420
2 Rue Briconnet, Nimes, 75002

Company Facts

32 Employees
IPO DateDec 6, 2017
CountryFR

Frequently Asked Questions

;